Breaking News

Aesica Appoints BD Managers

July 15, 2013

Thomas and Ross to drive business expansion efforts

Sven Thomas and David Ross have been appointed business development managers at Aesica. They will work to increase sales for the company’s integrated API, formulation development and manufacturing services to support clients manufacturing and development needs.
 
Mr. Ross will focus on the UK, Ireland and Scandinavia and Mr. Thomas will handle Central and Eastern Europe with an emphasis on expanding business from Germany and Eastern Europe. Along with Nicholas Micheaud, responsible for Southwestern Europe, Mr. Ross and Mr. Thomas report to Jeremy Drummond, the sales director.
 
Mr. Thomas brings extensive pharmaceutical manufacturing experience having previously worked for UCB. Mr. Ross has wide-ranging experience in contract research and contract manufacturing having held positions with Patheon, Catalant and Ipsen.
 
Mr. Thomas said, “I am delighted to take on my new position at Aesica and to play a key role in driving forward our services in the German market, as well as Eastern Europe. Indeed, the fact that we have site facilities geographically situated in Monheim and Zwickau as well as in Italy and the UK, ensures that Aesica is well situated to deliver reliable services to customers from all of Europe.”
             
David Ross said, “I very much look forward to playing a key regional role in driving new business across the UK, Ireland and Scandinavia. The integrated nature, scale and range of our service offering and our track record of transferring in new technologies stand us out in the highly competitive CDMO market place.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important